Progress in melanoma modelling in vitro
Open accessAbstract
Melanoma is one of the most studied neoplasia, although laboratory techniques used for investigating this tumor are not fully reliable. Animal models may not predict the human response due to differences in skin physiology and immunity. In addition, international guidelines recommend to develop processes that contribute to the reduction, refinement and replacement of animals for experiments (3Rs). Adherent cell culture has been widely used for the study of melanoma to obtain important information regarding melanoma biology. Nonetheless, these cells grow in adhesion on the culture substrate which differs considerably from the situation in vivo. Melanoma grows in a 3D spatial conformation where cells are subjected to a heterogeneous exposure to oxygen and nutrient. In addition, cell‐cell and cell‐matrix interaction play a crucial role in the pathobiology of the tumor as well as in the response to therapeutic agents. To better study, melanoma new techniques, including spherical models, tumorospheres and melanoma skin equivalents, have been developed. These 3D models allow to study tumors in a microenvironment that is more close to the in vivo situation and are less expensive and time‐consuming than animal studies. This review will also describe the new technologies applied to skin reconstructs such as organ‐on‐a‐chip that allows skin perfusion through microfluidic platforms. 3D in vitro models, based on the new technologies, are becoming more sophisticated, representing at a great extent the in vivo situation, the “perfect” model that will allow less involvement of animals up to their complete replacement, is still far from being achieved.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738 · see citing works
Reynolds, B. A., & Weiss, S. (1992) · Science · doi:10.1126/science.1553558 · Cited by 5,413 · see citing works
Bhatia, S. N., & Ingber, D. E. (2014) · Nature Biotechnology · doi:10.1038/nbt.2989 · Cited by 3,305 · see citing works
Clarke, M. F., Dick, J. E., Dirks, P. B., Eaves, C., Jamieson, C., Jones, D. L., Visvader, J., Weissman, I. L., & Wahl, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3126 · Cited by 3,124 · see citing works
Genomic responses in mouse models poorly mimic human inflammatory diseases
Seok, J., Warren, H. S., Cuenca, A. G., Mindrinos, M. N., Baker, H. V., Xu, W., Richards, D. R., McDonald-Smith, G. P., Gao, H., Hennessy, L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222878110 · Cited by 3,005 · see citing works
Prospective Identification of Tumorigenic Prostate Cancer Stem Cells
Collins, A. T., Berry, P. A., Hyde, C. F., Stower, M. J., & Maitland, N. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2018 · Cited by 2,821 · see citing works
Stromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,291 · see citing works
Melanin pigmentation in mammalian skin and its hormonal regulation
Slominski, A., Tobin, D. J., Shibahara, S., & Wortsman, J. (2004) · Physiological Reviews · doi:10.1152/physrev.00044.2003 · Cited by 2,015 · see citing works
Xu, D., He, X., Chang, Y., Sun, S., Xu, C., & Lin, J. (2012) · Hepatogastroenterology · doi:10.5754/hge12458 · Cited by 1,977 · see citing works
Cell and environment interactions in tumor microregions: the multicell spheroid model.
Sutherland, R. M. (1988) · Science · doi:10.1126/science.2451290 · Cited by 1,803 · see citing works
Spheroid-based drug screen: Considerations and practical approach
Friedrich, J., Seidel, C., Ebner, R., & Kunz-Schughart, L. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.226 · Cited by 1,742 · see citing works
Ponti, D., Costa, A., Zaffaroni, N., Pratesi, G., Petrangolini, G., Coradini, D., Pilotti, S., Pierotti, M. A., & Daidone, M. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0626 · Cited by 1,725 · see citing works
Identification and expansion of the tumorigenic lung cancer stem cell population
Eramo, A., Lotti, F., Sette, G., Pilozzi, E., Biffoni, M., Virgilio, A. D., Conticello, C., Ruco, L., Peschle, C., & Maria, R. D. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402283 · Cited by 1,707 · see citing works
Multicellular tumor spheroids: An underestimated tool is catching up again
Hirschhaeuser, F., Menne, H., Dittfeld, C., West, J., Mueller-Klieser, W., & Kunz-Schughart, L. A. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.01.012 · Cited by 1,674 · see citing works
Identification of cells initiating human melanomas
Schatton, T., Murphy, G. F., Frank, N. Y., Yamaura, K., Waaga-Gasser, A. M., Gasser, M., Zhan, Q., Jordan, S., Duncan, L. M., Weishaupt, C., et al. (2008) · Nature · doi:10.1038/nature06489 · Cited by 1,408 · see citing works
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
Tsai, J., Lee, J. T., Wang, W., Zhang, J., Cho, H., Mamo, S., Bremer, R., Gillette, S., Kong, J., Haass, N. K., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711741105 · Cited by 1,346 · see citing works
Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
Zhang, S., Balch, C., Chan, M. W. Y., Lai, H., Matei, D. E., Schilder, J. M., Yan, P. S., Huang, T. H. ‐., & Nephew, K. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0364 · Cited by 1,292 · see citing works
A tumorigenic subpopulation with stem cell properties in melanomas
Fang, D., Nguyen, T. K., Leishear, K., Finko, R., Kulp, A. N., Hotz, S., Van Belle, P. A., Xu, X., Elder, D. E., & Herlyn, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1343 · Cited by 1,280 · see citing works
Recent advances in three‐dimensional multicellular spheroid culture for biomedical research
Lin, R., & Chang, H. (2008) · Biotechnology Journal · doi:10.1002/biot.200700228 · Cited by 1,264 · see citing works
Spherical Cancer Models in Tumor Biology
Weiswald, L., Bellet, D. H., & Dangles‐Marie, V. (2015) · Neoplasia · doi:10.1016/j.neo.2014.12.004 · Cited by 1,138 · see citing works
Lost in translation: animal models and clinical trials in cancer treatment.
(2014) · Europe PMC (PubMed Central) · Cited by 1,033 · see citing works
A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma
Clark, W. H., Elder, D. E., Guerry, D., Epstein, M. N., Greene, M. H., & Horn, M. V. (1984) · Human Pathology · doi:10.1016/s0046-8177(84)80310-x · Cited by 977 · see citing works
The use of 3-d cultures for high-throughput screening: the multicellular spheroid model.
Kunz-Schughart, L. A., Freyer, J. P., Hofstaedter, F., & Ebner, R. (2004) · SLAS DISCOVERY · doi:10.1177/1087057104265040 · Cited by 797 · see citing works
Cancer stem cells in nervous system tumors
Singh, S. K., Clarke, I. D., Hide, T., & Dirks, P. B. (2004) · Oncogene · doi:10.1038/sj.onc.1207946 · Cited by 731 · see citing works
Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271
Boiko, A. D., Razorenova, O. V., van de Rijn, M., Swetter, S. M., Johnson, D. L., Ly, D. P., Butler, P. D., Yang, G. P., Joshua, B., Kaplan, M. J., et al. (2010) · Nature · doi:10.1038/nature09161 · Cited by 714 · see citing works
Loessner, D., Stok, K. S., Lutolf, M. P., Hutmacher, D. W., Clements, J. A., & Rizzi, S. C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.07.064 · Cited by 602 · see citing works
Growth of Multicell Spheroids in Tissue Culture as a Model of Nodular Carcinomas 2
Sutherland, R. M., McCredie, J. A., & Inch, W. R. (1971) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/46.1.113 · Cited by 585 · see citing works
Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential
Monzani, E., Facchetti, F., Galmozzi, E., Corsini, E., Benetti, A., Cavazzin, C., Gritti, A., Piccinini, A., Porro, D., Santinami, M., et al. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.01.017 · Cited by 556 · see citing works
3D Bioprinting for Organ Regeneration
Cui, H., Nowicki, M. A., Fisher, J. P., & Zhang, L. G. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201601118 · Cited by 542 · see citing works
Khanna, C. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh261 · Cited by 466 · see citing works
Alessandri, K., Sarangi, B. R., Gurchenkov, V., Sinha, B., Kießling, T. R., Fetler, L., Rico, F., Simon Scheuring, A., Lamaze, C., Simon, A. Y., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309482110 · Cited by 461 · see citing works
3D bioprinting of functional human skin: production and in vivo analysis
Cubo, N., García, M., del Cañizo, J. F., Velasco, D., & Jorcano, J. L. (2016) · Biofabrication · doi:10.1088/1758-5090/9/1/015006 · Cited by 458 · see citing works
Cell tension, matrix mechanics, and cancer development
Huang, S., & Ingber, D. E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.009 · Cited by 426 · see citing works
High-resolution imaging of the dynamic tumor cell–vascular interface in transparent zebrafish
Stoletov, K. V., Montel, V., Lester, R. D., Gonias, S. L., & Klemke, R. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703446104 · Cited by 324 · see citing works
Sahlgren, C., Meinander, A., Zhang, H., Cheng, F., Preis, M., Xu, C., Salminen, T. A., Toivola, D. M., Abankwa, D., Rosling, A., et al. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700258 · Cited by 315 · see citing works
Haldi, M., Ton, C., Seng, W. L., & McGrath, P. (2006) · Angiogenesis · doi:10.1007/s10456-006-9040-2 · Cited by 305 · see citing works
LIFE ISN'T FLAT: TAKING CANCER BIOLOGY TO THE NEXT DIMENSION
Smalley, K. S. M., Lioni, M., & Herlyn, M. (2006) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1290/0604027.1 · Cited by 303 · see citing works
Skin integrated with perfusable vascular channels on a chip
Mori, N., Morimoto, Y., & Takeuchi, S. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.11.031 · Cited by 299 · see citing works
Artificial skin in perspective: concepts and applications
Brohem, C. A., Cardeal, L. B. D. S., Tiago, M., Soengas, M. S., Barros, S. B. D. M., & Maria–Engler, S. S. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00786.x · Cited by 267 · see citing works
Pumpless microfluidic platform for drug testing on human skin equivalents
Abaci, H. E., Gledhill, K., Guo, Z., Christiano, A. M., & Shuler, M. L. (2014) · Lab on a Chip · doi:10.1039/c4lc00999a · Cited by 267 · see citing works
Sodek, K. L., Ringuette, M. J., & Brown, T. J. (2009) · International Journal of Cancer · doi:10.1002/ijc.24188 · Cited by 248 · see citing works
Human Melanoma Progression in Skin Reconstructs
Meier, F. E., Nesbit, M., Hsu, M., Martin, B. G., Belle, P. A. V., Elder, D. E., Schaumburg‐Lever, G., Garbe, C., Walz, T. M., DONATIEN, P. D., et al. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64719-0 · Cited by 226 · see citing works
Melanoma miRNA trafficking controls tumour primary niche formation
Dror, S., Sander, L., Doron, H., Sheinboim, D., Barzilai, A., Dishon, Y., Apcher, S., Golan, T., Greenberger, S., Barshack, I., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3399 · Cited by 214 · see citing works
Three‐dimensional cell culture models for anticancer drug screening: Worth the effort?
Verjans, E., Doijen, J., Luyten, W., Landuyt, B., & Schoofs, L. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26052 · Cited by 212 · see citing works
The multifactorial role of the 3Rs in shifting the harm-benefit analysis in animal models of disease
Graham, M. L., & Prescott, M. J. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.040 · Cited by 197 · see citing works
Sensi, M., Nicolini, G., Petti, C., Bersani, I., Lozupone, F., Molla, A., Vegetti, C., Nonaka, D., Mortarini, R., Parmiani, G., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209379 · Cited by 183 · see citing works
Karlsson, H., Fryknäs, M., Larsson, R., & Nygren, P. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.03.026 · Cited by 180 · see citing works
Hanging-drop multicellular spheroids as a model of tumour angiogenesis
Timmins, N., Dietmair, S., & Nielsen, L. K. (2004) · Angiogenesis · doi:10.1007/s10456-004-8911-7 · Cited by 177 · see citing works
Serebriiskii, I. G., Castelló-Cros, R., Lamb, A., Golemis, E. A., & Cukierman, E. (2008) · Matrix Biology · doi:10.1016/j.matbio.2008.02.008 · Cited by 176 · see citing works
Dangles‐Marie, V., Pocard, M. D., Richon, S., Weiswald, L., Assayag, F., Saulnier, P., Judde, J., Janneau, J.-L., Auger, N., Validire, P., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-0594 · Cited by 175 · see citing works
Vörsmann, H., Groeber, F., Walles, H., Busch, S., Beissert, S., Walczak, H., & Kulms, D. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.249 · Cited by 168 · see citing works
Lee, J. T., Li, L., Brafford, P. A., van den Eijnden, M., Halloran, M. B., Sproesser, K., Haass, N. K., Smalley, K. S. M., Tsai, J. Y., Bollag, G. E., et al. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00763.x · Cited by 165 · see citing works
Melanoma: New Insights and New Therapies
Nikolaou, V. A., Stratigos, A., Flaherty, K. T., & Tsao, H. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.421 · Cited by 164 · see citing works
Exploring the tumour environment: cancer-associated fibroblasts as targets in cancer therapy
Micke, P., & Östman, A. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.6.1217 · Cited by 162 · see citing works
Galactosylated alginate as a scaffold for hepatocytes entrapment
Yang, J., Goto, M., Ise, H., Cho, C.-S., & Akaike, T. (2002) · Biomaterials · doi:10.1016/s0142-9612(01)00129-6 · Cited by 153 · see citing works
Gammaherpesviruses and “Hit-and-Run” Oncogenesis
Ambinder, R. F. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64697-4 · Cited by 148 · see citing works
In vitro 3D Full‐Thickness Skin‐Equivalent Tissue Model Using Silk and Collagen Biomaterials
Bellas, E., Seiberg, M., Garlick, J. A., & Kaplan, D. L. (2012) · Macromolecular Bioscience · doi:10.1002/mabi.201200262 · Cited by 148 · see citing works
Isolation and identification of cancer stem-like cells from murine melanoma cell lines.
Dou, J., Pan, M., Wen, P., et al. (2007) · PubMed · Cited by 138 · see citing works
Rambow, F., Job, B., Petit, V., Gesbert, F., Delmas, V., Seberg, H., Meurice, G., Otterloo, E. V., Dessen, P., Robert, C., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.037 · Cited by 118 · see citing works
Modeling Melanoma In Vitro and In Vivo
Beaumont, K. A., Mohana‐Kumaran, N., & Haass, N. K. (2013) · Healthcare · doi:10.3390/healthcare2010027 · Cited by 112 · see citing works
Modeling and quantification of cancer cell invasion through collagen type I matrices
Wever, O. D., Hendrix, A., Boeck, A. D., Westbroek, W., Braems, G., Emami, S., Sabbah, M., Gespach, C. P., & Bracke, M. (2009) · The International Journal of Developmental Biology · doi:10.1387/ijdb.092948ow · Cited by 107 · see citing works
A Novel Fully Humanized 3D Skin Equivalent to Model Early Melanoma Invasion
Hill, D. S., Robinson, N. D. P., Caley, M. P., Chen, M., O’Toole, E. A., Armstrong, J. L., Przyborski, S. A., & Lovat, P. E. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0394 · Cited by 106 · see citing works
Next generation human skin constructs as advanced tools for drug development
Abaci, H., Guo, Z., Doucet, Y., Jacków, J., & Christiano, A. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217712690 · Cited by 104 · see citing works
Spontaneous Tumors and Common Diseases in Three Types of Hamsters2
Pour, P. M., Althoff, J., Salmasi, S. Z., et al. (1979) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/63.3.797 · Cited by 99 · see citing works
Slingluff, C. L., Colella, T. A., Thompson, L. W., et al. (2000) · Cancer Immunology Immunotherapy · doi:10.1007/s002620050015 · Cited by 95 · see citing works
Engineering a 3D microfluidic culture platform for tumor-treating field application
Pavesi, A., Adriani, G., Tay, A. K. P., Warkiani, M. E., Yeap, W. H., Wong, S. C., & Kamm, R. D. (2016) · Scientific Reports · doi:10.1038/srep26584 · Cited by 84 · see citing works
Kosten, I., Spiekstra, S. W., de Gruijl, T. D., & Gibbs, S. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.05.017 · Cited by 82 · see citing works
Perego, M., Tortoreto, M., Tragni, G., et al. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.69 · Cited by 82 · see citing works
In Vitro Modeling of Mechanics in Cancer Metastasis
Malandrino, A., Kamm, R. D., & Moeendarbary, E. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00041 · Cited by 78 · see citing works
A microfluidic platform for drug screening in a 3D cancer microenvironment
Pandya, H. J., Dhingra, K., Prabhakar, D., Chandrasekar, V., Natarajan, S. K., Vasan, A. S., Kulkarni, A., & Shafiee, H. (2017) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2017.03.054 · Cited by 76 · see citing works
Klimkiewicz, K., Weglarczyk, K., Collet, G., Paprocka, M., Guichard, A., Sarna, M., Jozkowicz, A., Dulak, J., Sarna, T., Grillon, C., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.03.006 · Cited by 70 · see citing works
Haridas, P., McGovern, J., McElwain, S. D., & Simpson, M. J. (2017) · PeerJ · doi:10.7717/peerj.3754 · Cited by 65 · see citing works
Scale-Up of Breast Cancer Stem Cell Aggregate Cultures to Suspension Bioreactors
Youn, B. S., Sen, A., Behie, L. A., Girgis-Gabardo, A., & Hassell, J. A. (2006) · Biotechnology Progress · doi:10.1021/bp050430z · Cited by 64 · see citing works
Proliferative activity and tumorigenic conversion: impact on cellular metabolism in 3-D culture
Kunz‐Schughart, L. A., Doetsch, J., Mueller‐Klieser, W., et al. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.278.4.c765 · Cited by 64 · see citing works
Akasov, R., Zaytseva‐Zotova, D., Burov, S. V., Leko, M. V., Dontenwill, M., Chiper, M., Vandamme, T., & Арнольдовна, М. Е. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.04.005 · Cited by 59 · see citing works
Mattei, F., Schiavoni, G., De Ninno, A., Lucarini, V., Sestili, P., Sistigu, A., Fragale, A., Sanchez, M., Spada, M., Gerardino, A., et al. (2014) · Journal of Immunotoxicology · doi:10.3109/1547691x.2014.891677 · Cited by 57 · see citing works
Generation of a tumor spheroid in a microgravity environment as a 3D model of melanoma
Marrero, B., Messina, J. L., & Heller, R. F. (2009) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-009-9217-2 · Cited by 56 · see citing works
von Euw, E. M., Barrio, M. M., Furman, D., Bianchini, M., Levy, E. M., Yee, C., Li, Y., Wainstok, R., & Mordoh, J. (2007) · Journal of Translational Medicine · doi:10.1186/1479-5876-5-19 · Cited by 55 · see citing works
Kelsall, S. R., & Mintz, B. (1998) · PubMed · Cited by 53 · see citing works
Gole, B., Alonso, M. B. D., Dolenc, V. V., & Lah, T. T. (2009) · Pathology & Oncology Research · doi:10.1007/s12253-009-9175-8 · Cited by 48 · see citing works
Raza, A., Colley, H. E., Baggaley, E., Sazanovich, I. V., Green, N. H., Weinstein, J. A., Botchway, S. W., MacNeil, S., & Haycock, J. W. (2017) · Scientific Reports · doi:10.1038/s41598-017-11153-9 · Cited by 48 · see citing works
Dawson, R., Upton, Z., Malda, J., & Harkin, D. G. (2006) · Transplantation · doi:10.1097/01.tp.0000226060.51572.89 · Cited by 44 · see citing works
Anti-Cancer Drug Validation: the Contribution of Tissue Engineered Models
Carvalho, M. R., Lima, D., Reis, R. L., Oliveira, J. M., & Correlo, V. M. (2017) · Stem Cell Reviews and Reports · doi:10.1007/s12015-017-9720-x · Cited by 44 · see citing works
Bekel, T., Henckel, K., Küster, H., et al. (2009) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2009.01.006 · Cited by 42 · see citing works
Old disease, new culprit: Tumor stem cells in cancer
Lee, J. T., & Herlyn, M. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21252 · Cited by 41 · see citing works
Meeting report: The future of preclinical mouse models in melanoma treatment is now
Merlino, G. T., Flaherty, K. T., Acquavella, N., et al. (2013) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12099 · Cited by 41 · see citing works
Combest, A. J., Roberts, P. J., Dillon, P. M., Sandison, K., Hanna, S. K., Ross, C., Habibi, S., Zamboni, B. A., Müller, M., Brunner, M., et al. (2012) · The Oncologist · doi:10.1634/theoncologist.2012-0274 · Cited by 41 · see citing works
Śniegocka, M., Podgórska, E., Plonka, P. M., Elas, M., Romanowska‐Dixon, B., Szczygieł, M., Zmijewski, M. A., Cichorek, M., Markiewicz, A., Brożyna, A. A., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041048 · Cited by 41 · see citing works
Saltari, A., Truzzi, F., Quadri, M., Lotti, R., Palazzo, E., Grisendi, G., Tiso, N., Marconi, A., & Pincelli, C. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.05.116 · Cited by 40 · see citing works
Self-citationThe In Vitro Spheroid Melanoma Cell Culture Assay: Cues on Tumor Initiation?
Schatton, T., & Frank, M. H. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.135 · Cited by 37 · see citing works
Nakazawa, K., Nakazawa, H., Sahuc, F., LEPAVEC, A., COLLOMBEL, C., & Damour, O. (1997) · Pigment Cell Research · doi:10.1111/j.1600-0749.1997.tb00696.x · Cited by 33 · see citing works
Spheroids: relation between tumour and endothelial cells
Oudar, O. (2000) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00080-9 · Cited by 33 · see citing works
Multicellular tumor spheroid formation in duplex microcapsules for analysis of chemosensitivity
Sakai, S., Inamoto, K., Liu, Y., Tanaka, S., Arii, S., & Taya, M. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02187.x · Cited by 27 · see citing works
Jansson, K., Kratz, G., & Hægerstrand, A. (1996) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/bf02722980 · Cited by 26 · see citing works
Cody, N. A. L., Zietarska, M., Filali‐Mouhim, A., Provencher, D. M., Mes‐Masson, A., & Tonin, P. N. (2008) · BMC Medical Genomics · doi:10.1186/1755-8794-1-34 · Cited by 25 · see citing works
BOMIRSKI MELANOMAS - A VERSATILE AND POWERFUL MODEL FOR PIGMENT CELL AND MELANOMA RESEARCH (REVIEW)
Slominski, A. T., & Paus, R. (1993) · International Journal of Oncology · doi:10.3892/ijo.2.2.221 · Cited by 24 · see citing works
Initial formation of IGROV1 ovarian cancer multicellular aggregates involves vitronectin
Kellouche, S., Fernandes, J., Leroy‐Dudal, J., Gallet, O., Dutoit, S., Poulain, L., & Carreiras, F. (2010) · Tumor Biology · doi:10.1007/s13277-010-0017-9 · Cited by 24 · see citing works
A Unique 3D In Vitro Cellular Invasion Assay
Quail, D. F., Maciel, T. J., Rogers, K. A., & Postovit, L.-M. M. (2012) · SLAS DISCOVERY · doi:10.1177/1087057112449863 · Cited by 14 · see citing works
Hauptmann, S., Budianto, D., Denkert, C., et al. (2003) · Oncology · doi:10.1159/000072344 · Cited by 13 · see citing works
Comparison of bleomycin and peplomycin toxicity on clonogenic tumor cells from various human tumors
Neumann, H., Runge, H., Fiebig, H. H., et al. (1986) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf00404401 · Cited by 2 · see citing works
Flagged first, then by citations
Research works printed but not linked: 101
- [1]1. K. Klimkiewicz, K. Weglarczyk, G. Collet, M. Paprocka, A. Guichard, M. Sarna, A. Jozkowicz, J. Dulak, T. Sarna, C. Grillon, C. Kieda, Cancer Lett. 2017, 396, 10.
- [2]2. H. Vörsmann, F. Groeber, H. Walles, S. Busch, S. Beissert, H. Walczak, D. Kulms, Cell Death Dis. 2013, 4, e719.
- [3]3. M. Sensi, G. Nicolini, C. Petti, I. Bersani, F. Lozupone, A. Molla, C. Vegetti, D. Nonaka, R. Mortarini, G. Parmiani, S. Fais, A. Anichini, Oncogene 2006, 25, 3357.
- [4]4. E. M. von Euw, M. M. Barrio, D. Furman, M. Bianchini, E. M. Levy, C. Yee, Y. Li, R. Wainstok, J. Mordoh, J. Transl. Med. 2007, 5, 19.
- [5]5. C. L. Slingluff Jr., T. A. Colella, L. Thompson, D. D. Graham, J. C. Skipper, J. Caldwell, L. Brinckerhoff, D. J. Kittlesen, D. H. Deacon, C. Oei, N. L. Harthun, E. L. Huczko, D. F. Hunt, T. L. Darrow, V. H. Engelhard, Cancer Immunol. Immunother. 2000, 48, 661.
- [6]6. V. A. Nikolaou, A. J. Stratigos, K. T. Flaherty, H. Tsao, J. Invest. Dermatol. 2012, 132, 854.
- [7]7. K. A. Beaumont, N. Mohana-Kumaran, N. K. Haass, Healthcare (Basel) 2013, 2, 27.
- [8]8. C. Khanna, K. Hunter, Carcinogenesis 2005, 26, 513.
- [9]9. G. Merlino, K. Flaherty, N. Acquavella, C. P. Day, A. Aplin, S. Holmen, S. Topalian, T. van Dyke, M. Herlyn, Pigment Cell Melanoma Res. 2013, 26, E8.
- [11]11. S. R. Kelsall, B. Mintz, Cancer Res. 1998, 58, 4061.
- [12]12. C. J. Kemp, Cold Spring Harb. Protoc. 2015, 10, 865.
- [13]13. J. Combest, P. J. Roberts, P. M. Dillon, K. Sandison, S. K. Hanna, C. Ross, S. Habibi, B. Zamboni, M. Müller, M. Brunner, N. E. Sharpless, W. C. Zamboni, Oncologist 2012, 17, 1303.
- [14]14. M. Śniegocka, E. Podgórska, P. M. Płonka, M. Elas, B. Romanowska- Dixon, M. Szczygieł, M. A. Żmijewski, M. Cichorek, A. Markiewicz, A. A. Brożyna, A. T. Słominski, K. Urbańska, Int. J. Mol. Sci. 2018, 19, 1048.
- [15]15. A. Slominski, R. Paus, Int. J. Oncol. 1993, 2, 221.
- [16]16. P. Pour, J. Althoff, S. Z. Salmasi, K. Stepan, J. Natl Cancer Inst. 1979, 63, 797.
- [17]17. M. Haldi, C. Ton, W. L. Seng, P. McGrath, Angiogenesis 2006, 9, 139.
- [18]18. K. Stoletov, V. Montel, R. D. Lester, S. L. Gonias, R. Klemke, Proc. Natl Acad. Sci. USA 2007, 104, 17406.
- [19]19. J. Seok, H. S. Warren, A. G. Cuenca, M. N. Mindrinos, H. V. Baker, W. Xu, D. R. Richards, G. P. McDonald-Smith, H. Gao, L. Hennessy, C. C. Finnerty, C. M. López, S. Honari, E. E. Moore, J. P. Minei, J. Cuschieri, P. E. Bankey, J. L. Johnson, J. Sperry, A. B. Nathens, T. R. Billiar, M. A. West, M. G. Jeschke, M. B. Klein, R. L. Gamelli, N. S. Gibran, B. H. Brownstein, C. Miller-Graziano, S. E. Calvano, P. H. Mason, J. P. Cobb, L. G. Rahme, S. F. Lowry, R. V. Maier, L. L. Moldawer, D. N. Herndon, R. W. Davis, W. Xiao, R. G. Tompkins, Inflammation and Host Response to Injury, Large Scale Collaborative Research Program, Proc. Natl Acad. Sci. USA 2013, 110, 3507.
- [20]20. I. W. Mak, N. Evaniew, M. Ghert, Am. J. Transl. Res. 2014, 6, 114.
- [21]21. M. L. Graham, M. J. Prescot, Eur. J. Pharmacol. 2015, 759, 19.
- [22]22. H. A. Neumann, H. M. Runge, H. H. Fiebig, R. Engelhardt, G. W. Löhr, J. Cancer Res. Clin. Oncol. 1986, 112, 165.
- [23]23. M. R. Carvalho, D. Lima, R. L. Reis, J. M. Oliveira, V. M. Correlo, Stem Cell Rev. 2017, 13, 347.
- [24]24. S. Huang, D. E. Ingber, Cancer Cell 2005, 8, 175.
- [25]25. F. Rambow, B. Job, V. Petit, F. Gesbert, V. Delmas, H. Seberg, G. Meurice, E. Van Otterloo, P. Dessen, C. Robert, D. Gautheret, R. A. Cornell, A. Sarasin, L. Larue, Cell Rep. 2015, 13, 840.
- [26]26. A. Malandrino, R. D. Kamm, E. Moeendarbary, ACS Biomater. Sci. Eng. 2018, 4, 294.
- [27]27. I. Serebriiskii, R. Castelló-Cros, A. Lamb, E. A. Golemis, E. Cukierman, Matrix Biol. 2008, 27, 573.
- [28]28. D. Loessner, K. S. Stok, M. P. Lutolf, D. W. Hutmacher, J. A. Clements, S. C. Rizzi, Biomaterials 2010, 31, 8494.
- [29]29. H. Karlsson, M. Fryknäs, R. Larsson, P. Nygren, Exp. Cell Res. 2012, 318, 1577.
- [30]30. R. M. Sutherland, J. A. McCredie, W. R. Inch, J. Natl Cancer Inst. 1971, 46, 113.
- [31]31. R. Z. Lin, H. Y. Chang, Biotechnol. J. 2008, 9, 1172.
- [32]32. L. A. Kunz-Schughart, J. P. Freyer, F. Hofstaedter, R. Ebner, J. Biomol. Screen. 2004, 9, 273.
- [33]33. N. A. Cody, M. Zietarska, A. Filali-Mouhim, D. M. Provencher, A. M. Mes-Masson, P. N. Tonin, BMC Med. Genomics 2008, 1, 34.
- [34]34. T. T. Chang, M. Hughes-Fulford, Tissue Eng. Part A 2009, 15, 55967.
- [36]36. A. Saltari, F. Truzzi, M. Quadri, R. Lotti, E. Palazzo, G. Grisendi, N. Tiso, A. Marconi, C. Pincelli, J. Invest. Dermatol. 2016, 136, 2049.
- [37]37. R. M. Sutherland, Science 1988, 240, 177.
- [38]38. V. Dangles-Marie, M. Pocard, S. Richon, L. B. Weiswald, F. Assayag, P. Saulnier, J. G. Juddle, J. L. Janneau, N. Auger, P. Validire, Cancer Res. 2007, 67, 398.
- [39]39. J. Friedrich, C. Seidel, R. Ebner, L. A. Kunz-Schughart, Nat. Protoc. 2009, 4, 309.
- [40]40. B. S. Youn, A. S. Sen, L. A. Behie, A. Girgis-Gabardo, J. A. Hassell, Biotechnol. Prog. 2006, 22, 801.
- [41]41. Y. Fang, R. M. Eglen, 3D Cell Cult. Drug Screen. Optim. 2017, 22, 456.
- [42]42. S. Sakai, K. Inamoto, Y. Liu, S. Tanaka, S. Arii, M. Taya, Cancer Sci. 2012, 103, 549.
- [43]43. S. Zhang, C. Balch, M. W. Chan, H. C. Lai, D. Matei, J. M. Schilder, P. S. Yan, T. H. Huang, K. P. Nephew, Cancer Res. 2008, 68, 4311.
- [44]44. K. Alessandri, B. R. Sarangi, V. V. Gurchenkov, B. Sinha, T. R. Kießling, L. Fetler, F. Rico, S. Scheuring, C. Lamaze, A. Simon, S. Geraldo, D. Vignjevic, H. Doméjean, L. Rolland, A. Funfak, J. Bibette, N. Bremond, P. Nassoy, Proc. Natl Acatd. Sci. U.S.A. 2013, 110, 14843.
- [45]45. S. Kellouche, J. Fernandes, J. Leroy Dudal, O. Gallet, S. Dutoit, L. Poulain, F. Carreiras, Tumor Biol. 2010, 31, 129.
- [46]46. R. Akasov, D. Zaytseva-Zotova, S. Burov, M. Leko, M. Dontenwill, M. Chiper, T. Vandamme, E. Markvicheva, Int. J. Pharm. 2016, 506, 1498.
- [47]47. J. Yang, M. Goto, H. Iso, C. S. Cho, T. Akaike, Biomaterials 2002, 23, 471.
- [48]48. E. T. Verjans, J. Doijen, W. Luyten, B. Landuyt, L. Schoofs, J. Cell. Physiol. 2018, 233, 2993.
- [49]49. X. Gong, C. Lin, J. Cheng, J. Su, H. Zhao, T. Liu, X. Wen, P. Zhao, PLoS ONE 2015, 10, 1371.
- [50]50. L. B. Weiswald, D. Bellet, V. Dangles-Marie, Neoplasia 2015, 17, 1.
- [51]51. F. Hirschhaeuser, M. Heike, C. Dittfeld, J. West, W. Mueller- Klieser, L. A. Kunz-Schughart, J. Biotechnol. 2010, 140, 3.
- [52]52. A. Raza, H. E. Colley, E. Baggaley, I. V. Sazanovich, N. H. Green, J. A. Weinstein, S. W. Botchway, S. MacNeil, J. W. Haycock, Sci. Rep. 2017, 7, 10743.
- [53]53. L. A. Kunz-Shugart, J. Doetsh, W. Muller-Klieser, K. Groebe, Am. J. Physiol. Cell Physiol. 2000, 278, C765.
- [54]54. D. F. Quail, J. T. Maciel, K. Rogers, L. M. Postovit, J. Biomol. Screen. 2012, 17, 1088.
- [55]55. K. L. Sodek, M. J. Ringuette, T. J. Brown, Int. J. Cancer 2009, 124, 2060.
- [56]56. B. Gole, M. B. Duran Alonso, V. Dolenc, T. Lah, Pathol. Oncol. Res. 2009, 15, 711.
- [57]57. S. Hauptmann, D. Budianto, C. Denkert, M. Kobel, L. Borsi, A. Siri, Oncology 2003, 65, 174.
- [58]58. O. De Wever, A. Hendrix, A. De Boeck, W. Westbroek, G. Breams, S. Emami, M. Sabbah, C. Gespach, M. Bracke, Int. J. Dev. Biol. 2010, 54, 887.
- [59]59. O. Oudar, Crit. Rev. Oncol. Hematol. 2000, 36, 99.
- [60]60. N. E. Timmins, S. Dietmair, L. K. Nielsen, Angiogenesis 2004, 7, 97.
- [61]61. B. Marrero, J. L. Messina, R. Heller, In Vitro Cell. Dev. Biol. Anim. 2009, 45, 523.
- [62]62. T. Shatton, M. K. Frank, J. Invest. Dermatol. 2010, 130, 1769.
- [63]63. T. Reya, S. J. Morrison, M. F. Clarke, I. L. Weissman, Nature 2001, 414, 105.
- [64]64. J. T. Lee, M. Herlyn, J. Cell. Physiol. 2007, 213, 603.
- [65]65. S. K. Singh, I. D. Clarke, T. Hide, P. B. Dirks, Oncogene 2004, 23, 7267.
- [66]66. D. Ponti, A. Costa, N. Zaffaroni, G. Pratesi, G. Petrangolini, D. Coradini, S. Pilotti, M. A. Pierotti, M. G. Daidone, Cancer Res. 2005, 65, 5506.
- [67]67. A. Eramo, F. Lotti, G. Sette, E. Pilozzi, M. Biffoni, A. Di Virgiglio, C. Conticello, L. Ruco, C. Peschle, R. De Maria, Cell Death Differ. 2008, 15, 504.
- [68]68. A. T. Collins, P. A. Berry, C. Hyde, M. J. Stower, N. J. Maitland, Cancer Res. 2005, 65, 10946.
- [69]69. M. Perego, M. Tortoreto, G. Tragni, L. Mariani, P. Deho, A. Carbone, M. Santinami, R. Patuzzo, P. D. Mina, A. Villa, G. Pratesi, G. Cossa, P. Perego, M. G. Daidone, M. R. Alison, G. Parmiani, L. Rivoltini, C. Castelli, J. Invest. Dermatol. 2010, 130, 1877.
- [70]70. B. A. Reynolds, S. Weiss, Science 1992, 255, 1707.
- [71]71. E. Monzani, F. Facchetti, E. Galmozzi, E. Corsini, A. Benetti, C. Cavazzin, A. Gritti, A. Piccinini, D. Porro, M. Santinami, G. Invernici, E. Parati, G. Alessandri, C. A. La Porta, Eur. J. Cancer 2007, 43, 935.
- [72]72. T. Schatton, G. F. Murphy, N. Y. Frank, K. Yamaura, A. M. Waaga- Gasser, M. Gasser, Q. Zhan, S. Jordan, L. M. Duncan, C. Weishaupt, R. C. Fuhlbrigge, T. S. Kupper, M. H. Sayegh, M. H. Frank, Nature 2008, 451, 345.
- [73]73. D. Fang, T. K. Nguyen, K. Leishear, R. Finko, A. N. Kulp, S. Hotz, P. A. Van Belle, X. Xu, D. E. Elder, M. Herlyn, Can. Res. 2005, 65, 9328.
- [74]74. J. Dou, M. Pan, P. Wen, Y. Li, Q. Tang, L. Chu, F. Zhao, C. Jiang, W. Hu, K. Hu, N. Gu, Cell. Mol. Immunol. 2007, 4, 467.
- [75]75. A. D. Boiko, O. V. Razorenova, M. van De Rijn, S. M. Swetter, D. L. Johnson, D. P. Ly, P. D. Butler, G. P. Yang, B. Joshua, M. J. Kaplan, M. T. Longaker, I. L. Weissman, Nature 2010, 466, 133.
- [76]76. M. F. Clarke, J. E. Dick, P. B. Dirks, C. J. Eaves, C. H. Jamieson, D. L. Jones, J. Visvader, I. L. Weissman, G. M. Wahl, Cancer Res. 2006, 66, 9339.
- [77]77. K. S. Smalley, M. Lioni, M. Herlyn, In Vitro Cell. Dev. Biol. Anim. 2006, 42, 242.
- [78]78. F. Meier, M. Nesbit, M.-Y. Hsu, B. Martin, P. Van Belle, D. E. Elder, G. Schaumburg-Lever, C. Garbe, T. M. Walz, P. Donatien, T. M. Crombleholme, M. Herlyn, Am. J. Pathol. 2000, 156, 1.
- [79]79. N. A. Bhowmick, E. G. Neilson, H. L. Moses, Nature 2004, 432, 332.
- [80]80. P. Micke, A. Ostman, Expert Opin. Ther. Targets. 2005, 9, 1217.
- [81]81. S. Dror, L. Sander, H. Schwartz, D. Sheinboim, A. Barzilai, Y. Dishon, S. Apcher, T. Golan, S. Greenberger, I. Barshack, H. Malcov, A. Zilberberg, L. Levin, M. Nessling, Y. Friedmann, V. Igras, O. Barzilay, H. Vaknine, R. Brenner, A. Zinger, A. Schroeder, P. Gonen, M. Khaled, N. Erez, J. D. Hoheisel, C. Levy, Nat. Cell Biol. 2016, 18, 1006.
- [83]83. C. A. Brohem, L. B. da Silva Cardeal, M. Tiago, M. S. Soengas, S. B. de Moraes Barros, S. S. Maria-Engler, Pigment Cell Melanoma Res. 2011, 24, 30.
- [84]84. P. Haridas, J. A. McGovern, S. D. L. McElwain, M. J. Simson, PeerJ 2017, 5, e3754.
- [85]85. M. Ponec, J. Kempenaar, J. Skin Pharmacol. 1995, 8, 499.
- [86]86. K. Jansson, G. Kratz, A. Haegerstrand, In Vitro Cell. Dev. Biol. Anim. 1996, 32, 53440.
- [87]87. K. Nakazawa, H. Nakazawa, F. Sahuc, A. Lepavec, C. Collombel, O. Damour, Pigment Cell Res. 1997, 10, 38290.
- [88]88. A. Slominski, D. J. Tobin, S. Shibahara, J. Wortsman, Physiol. Rev. 2004, 84, 1155.
- [89]89. R. A. Dawson, Z. Upton, J. Malda, D. G. Harkin, Transplantation 2006, 81, 1668.
- [90]90. D. S. Hill, N. D. P. Robinson, M. P. Caley, M. Chen, E. A. O'Toole, J. L. Armstrong, S. Przyborski, P. E. Lovat, Mol. Cancer Ther. 2015, 14, 2665.
- [91]91. W. H. Clark Jr., D. E. Elder, D. I. V. Guerry, M. N. Epstein, M. H. Greene, M. Van Horn, Hum. Pathol. 1984, 15, 1147.
- [92]92. J. Tsai, J. T. Lee, W. Wang, J. Zhang, H. Cho, S. Mamo, R. Bremer, S. Gillette, J. Kong, N. K. Haass, K. Sproesser, L. Li, K. S. Smalley, D. Fong, Y. L. Zhu, A. Marimuthu, H. Nguyen, B. Lam, J. Liu, I. Cheung, J. Rice, Y. Suzuki, C. Luu, C. Settachatgul, R. Shellooe, J. Cantwell, S. H. Kim, J. Schlessinger, K. Y. Zhang, B. L. West, B. Powell, G. Habets, C. Zhang, P. N. Ibrahim, P. Hirth, D. R. Artis, M. Herlyn, G. Bollag, Proc. Natl Acad. Sci. USA 2008, 105, 3041.
- [93]93. J. T. Lee, L. Li, P. A. Brafford, M. van den Eijnden, M. B. Halloran, K. Sproesser, N. K. Haass, K. S. Smalley, J. Tsai, G. Bollang, M. Herlyn, Pigment Cell Melanoma Res. 2010, 23, 820.
- [94]94. E. Bellas, M. Seiberg, J. Garlick, D. L. Kaplan, Macromol. Biosci. 2012, 12, 1627.
- [95]95. I. J. Kosten, S. W. Spiekstra, T. D. de Gruijl, S. Gibbs, Toxicol. Appl. Pharmacol. 2015, 287, 35.
- [96]96. N. Cubo, M. Garcia, J. F. Del Cañizo, D. Velasco, J. L. Jorcano, Biofabrication 2016, 9, 015006.
- [97]97. H. Cui, M. Nowicki, J. P. Fisher, L. G. Zhang, Adv. Healthc. Mater. 2017, 6, 1.
- [98]98. S. N. Bhatia, D. E. Ingber, Nat. Biotechnol. 2014, 32, 760.
- [99]99. A. Pavesi, G. Adriani, A. Tay, M. E. Warkiani, W. H. Yeap, S. C. Wong, R. D. Kamm, Sci. Rep. 2016, 24, 26584.
- [100]100. H. E. Abaci, Z. Guo, Y. Doucet, J. Jacków, A. Christiano, Exp. Biol. Med. (Maywood). 2017, 242, 1657.
- [101]101. N. Mori, Y. Morimoto, S. Takeuchi, Biomaterials 2017, 116, 48.
- [102]102. H. E. Abaci, K. Gledhill, Z. Guo, A. M. Christiano, M. L. Shuler, Lab Chip 2015, 15, 882.
- [103]103. H. J. Pandya, K. Dhingra, D. Prabhakar, V. Chandrasekar, S. K. Natarajan, A. S. Vasan, A. Kulkarni, H. Shafiee, Biosens. Bioelectron. 2017, 94, 632.
- [104]104. F. Mattei, G. Schiavoni, A. De Ninno, V. Lucarini, P. Sestili, A. Sistigu, A. Fragale, M. Sanchez, M. Spada, A. Gerardino, F. Belardelli, L. Businaro, L. Gabriele, J. Immunotoxicol. 2014, 11, 337.
Cited by
Sorted by citations
Human skin models: From healthy to disease-mimetic systems; characteristics and applications
Moniz, T., Costa Lima, S. A., & Reis, S. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15184 · Cited by 80 · see citing works
A layered cancer-on-a-chip system for anticancer drug screening and disease modeling
Flont, M., Dybko, A., & Jastrzębska, E. (2023) · The Analyst · doi:10.1039/d3an00959a · Cited by 21 · see citing works
- Authors
- Marconi, A., Quadri, M., Saltari, A., & Pincelli, C.
- Affiliations
- University of Modena and Reggio Emilia (IT)
- Corresponding author
- Marconi, Alessandra
- Venue
- Experimental Dermatology
- Publisher
- Wiley
- Published
- 2018-05
- Volume
- 27
- Issue
- 5
- Pages
- 578-586
- ISSN
- 0906-6705 (ISSN-L)
- 1600-0625
- OpenAlex
- W2802665732
- Cited by
- 51
- References
- 100
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 6 · 2023: 11 · 2022: 9 · 2021: 7 · 2020: 6 · 2019: 2 · 2018: 2
- FWCI
- 0.35
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Experimental Dermatology (publishedVersion)
- PubMed (publishedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Keywords
- melanoma, in vitro model, 3D tumor models, organ-on-a-chip, microfluidics, 3Rs, animal model limitations, cell-matrix interactions, cell-cell interactions, tumor microenvironment
- MeSH terms
- Humans, Melanoma, Models, Biological, Cell Culture Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review